Research shows 56% of patients on GLP-1RAs had much gastric content despite following standard fasting guidelines, while only 19% of non-users showed similar results [33]
Beyond improving health, these medications enhance quality of life and lower the risk of life-threatening events, including strokes, heart failure, and all-cause mortality
It is important to recognize that sexual dysfunction is common in individuals with obesity and type 2 diabetesthe very populations for whom semaglutide is prescribed
If you suffered serious side effects after taking Mounjaro, you may have legal options
Combined SGLT2i and GLP-1RA therapy resulted in a significantly lower risk of all-cause death, non-fatal myocardial infarction, and non-fatal stroke at 12 months than SGLT2i monotherapy (HR, 1.77